Long Coronary Artery Disease
Conditions
Brief summary
The utilization of everolimus-eluting coronary stents in a coronary artery diseases is effective in reducing both repeat revascularization and major adverse cardiac events within two year follow-up. To evaluate the procedural, short and long term clinical outcomes of multiple everolimus-eluting coronary stent implantation in long (\>30mm) coronary lesions.
Interventions
Everolimus-eluting stent implantation in patients with long coronary artery disease
Sponsors
Society for Advancement of Coronary Intervention Research
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
1. Age ≥20 years and are able to undergo CABG 2. Females who are not pregnant 3. Patients who present with angina symptoms or myocardial ischemia 4. Patients available for post-procedural observation and coronary angiography at 24 months 5. Patients who have signed patient informed consent 6. Lesion length is more than 30mm 7. De novo lesion or non-stented restenosed lesion
Exclusion criteria
1. Patients contraindicated for antiplatelet therapy or anticoagulant therapy 2. Patients with significant allergic reaction to contrast medium 3. Chronic total occlusion 4. Lesion with TIMI0 5. Patients with chronic renal failure (SCr\>3.0mg/dl) -
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Target lesion revascularization rate | 1 year |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Angiographic restenosis | 9 months | — |
| Target vessel revascularization | 1 year | — |
| Technical success | Initial | — |
| Incidences of acute, sub acute, and late stent thrombosis | 2 year | — |
| Incidence of MACCE | 2 year | defined as cardiac death, nonfatal acute myocardial infarction and cerebrovascular events |
| Target lesion revascularization | 2 year | — |
Countries
Japan
Outcome results
None listed